MedAdvisor Statistics

Total Valuation

MedAdvisor has a market cap or net worth of AUD 57.38 million. The enterprise value is 63.88 million.

Market Cap	57.38M
Enterprise Value	63.88M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

MedAdvisor has 597.72 million shares outstanding. The number of shares has decreased by -1.88% in one year.

Current Share Class	n/a
Shares Outstanding	597.72M
Shares Change (YoY)	-1.88%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	3.85%
Owned by Institutions (%)	36.30%
Float	366.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	1.02
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.66
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.27

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.34.

Current Ratio	1.25
Quick Ratio	1.14
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	-1.56
Interest Coverage	-1.09

Financial Efficiency

Return on equity (ROE) is -8.34% and return on invested capital (ROIC) is -2.06%.

Return on Equity (ROE)	-8.34%
Return on Assets (ROA)	-1.35%
Return on Invested Capital (ROIC)	-2.06%
Return on Capital Employed (ROCE)	-3.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.94
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.46% in the last 52 weeks. The beta is 1.00, so MedAdvisor's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-67.46%
50-Day Moving Average	0.12
200-Day Moving Average	0.28
Relative Strength Index (RSI)	43.58
Average Volume (20 Days)	881,842

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedAdvisor had revenue of AUD 103.66 million and -4.68 million in losses. Loss per share was -0.01.

Revenue	103.66M
Gross Profit	20.24M
Operating Income	-2.37M
Pretax Income	-4.47M
Net Income	-4.68M
EBITDA	-2.39M
EBIT	-2.37M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 12.40 million in cash and 18.90 million in debt, giving a net cash position of -6.50 million or -0.01 per share.

Cash & Cash Equivalents	12.40M
Total Debt	18.90M
Net Cash	-6.50M
Net Cash Per Share	-0.01
Equity (Book Value)	56.37M
Book Value Per Share	0.10
Working Capital	5.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.98 million and capital expenditures -146,059, giving a free cash flow of -12.12 million.

Operating Cash Flow	-11.98M
Capital Expenditures	-146,059
Free Cash Flow	-12.12M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 19.53%, with operating and profit margins of -2.29% and -4.51%.

Gross Margin	19.53%
Operating Margin	-2.29%
Pretax Margin	-4.31%
Profit Margin	-4.51%
EBITDA Margin	-2.31%
EBIT Margin	-2.29%
FCF Margin	n/a

Dividends & Yields

MedAdvisor does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.88%
Shareholder Yield	1.88%
Earnings Yield	-8.15%
FCF Yield	-21.13%

Stock Splits

The last stock split was on November 20, 2019. It was a reverse split with a ratio of 0.1428571429.

Last Split Date	Nov 20, 2019
Split Type	Reverse
Split Ratio	0.1428571429

Scores

MedAdvisor has an Altman Z-Score of 2.7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.7
Piotroski F-Score	n/a